Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Rise In Air Pollution
3.2.2. High Prevalence Of Chronic Respiratory Diseases
3.2.3. Surging Indoor Air Pollutants
3.2.4. Rising Geriatric Population
3.2.5. Growing Prevalence Of Copd And Asthma
3.3. Key Restraints
3.3.1. Data Security Concern Hampers The Market
3.3.2. High Cost Of Asthma And Copd Treatment

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Evolution Of Smart Inhalers
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Product
5.1. Smart Inhalers
5.2. Smart Nebulizer
5.2.1. Types Of Nebulizer (Qualitative)
5.2.1.1. Pneumatic Nebulizer
5.2.1.2. Ultrasonic Nebulizer
5.2.1.3. Mesh Nebulizer
5.2.2. Nebulizer By Portability (Qualitative)
5.2.2.1. Tabletop Nebulizer
5.2.2.2. Portable Nebulizer
5.2.3. Nebulizer By Sales Channel (Qualitative)
5.2.3.1. Direct Purchase
5.2.3.2. Online Purchase

6. Market By Indication
6.1. Asthma
6.2. Copd

7. Market By Distribution Channel
7.1. Hospital
7.2. Pharmacy

8. Geographical Analysis
8.1. North America
8.1.1. The United States
8.1.2. Canada

9. Company Profiles
9.1. 3M Company
9.2. Adherium Limited
9.3. Agilent Technologies Inc
9.4. Astrazeneca Plc
9.5. Boehringer Ingelheim Gmbh
9.6. Cohero Health Inc
9.7. Glaxosmithkline Plc
9.8. Koninklijke Philips N.V
9.9. Novartis Ag
9.10. Opko Health Inc
9.11. Resmed Inc (Propeller Health)
9.12. Teva Pharmaceutical Industries Limited
9.13. Vectura Group Plc



List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: North America Smart Inhalers Market, By Product, In 2019
Figure 6: North America Smart Inhalers Market, By Smart Inhalers, 2019-2028 (In $ Thousand)
Figure 7: North America Smart Inhalers Market, By Smart Nebulizer, 2019-2028 (In $ Thousand)
Figure 8: North America Smart Inhalers Market, By Indication, In 2019
Figure 9: North America Smart Inhalers Market, By Asthma, 2019-2028 (In $ Thousand)
Figure 10: North America Smart Inhalers Market, By Copd, 2019-2028 (In $ Thousand)
Figure 11: North America Smart Inhalers Market, By Distribution Channel, In 2019
Figure 12: North America Smart Inhalers Market, By Hospital, 2019-2028 (In $ Thousand)
Figure 13: North America Smart Inhalers Market, By Pharmacy, 2019-2028 (In $ Thousand)
Figure 14: North America Smart Inhalers Market, Country Outlook, 2019 & 2028 (In %)
Figure 15: The United States Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 16: Canada Smart Inhalers Market, 2019-2028 (In $ Thousand)


List of Tables


TABLE 1: MARKET SNAPSHOT - SMART INHALERS
TABLE 2: NORTH AMERICA SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 3: NORTH AMERICA SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 4: NORTH AMERICA SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 5: NORTH AMERICA SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 6: NORTH AMERICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 7: NORTH AMERICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 8: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 9: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)